RHP vs MIRM Comparison

Ryman Hospitality Properties Inc is a lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and country music entertainment experiences. Its core holdings include meetings-focused resorts that are managed by Marriott under the Gaylord Hotels and JW Marriott brands. The company's operations are organized into three segments: Hospitality, Entertainment, and Corporate and Other. The majority of its revenue is generated from the Hospitality segment, which includes the Gaylord Hotels properties, JW Marriott properties, the Inn at Opryland, and the AC Hotel in its portfolio. The Entertainment segment includes the entertainment and media assets comprising Opry Entertainment Group, and the Corporate and Other segment includes corporate expenses.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.